Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00145418
Status:
TERMINATED
Last Update Posted:
2014-06-30
First Post:
2005-09-01
Brief Title:
Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer
Sponsor:
Oncology Specialists SC
Organization:
Oncology Specialists SC
Organization Data
Organization:
Oncology Specialists SC
Class:
OTHER
Study ID:
OX-03-137 0409
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Oncology Specialists SC
Lead Sponsor Class:
OTHER
Responsible Party:
Dr Sigrun Hallmeyer
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Oncology Specialists SC
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Sanofi-Synthelabo | INDUSTRY |